reduce basal insulin when starting glp-1 receptor agonist Combination of and agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes? | Diabetology & Metabolic Syndrome Glucometabolic outcomes of GLP-1 receptor
Description
doi: 10.2337/dc15-0843
GLP-1 can control the secretion of various neurotransmitters, the progression of neuroinflammation, and the increase in insulin sensitivity in the brain (Athauda and Foltynie, 2016)
You dial your dose and the pen delivers it
Large meals, greasy foods, fried foods, very rich meals, alcohol, carbonated drinks, and heavy late-night eating may sit in the stomach longer and trigger nausea, reflux, burping, or vomiting
